Scientists develop ‘off the shelf’ engineered stem cells to treat aggressive brain cancer
Investigators have devised a novel therapeutic method for treating glioblastomas post-surgery by using stem cells taken from healthy donors engineered to attack GBM-specific tumor cells. This strategy demonstrated profound efficacy in preclinical models of GBM, with 100 percent of mice living over 90 days after treatment.
Materials provided by Brigham and Women’s Hospital. Note: Content may be edited for style and length.
Source link aaaaa